Literature DB >> 19645746

PolyADP-ribosylation is required for long-term memory formation in mammals.

Shmuel Goldberg1, Leonid Visochek, Eliezer Giladi, Illana Gozes, Malka Cohen-Armon.   

Abstract

PolyADP-ribosylation is a post-translational modification of nuclear proteins, catalyzed by polyADP-ribose polymerases (PARPs). In the nucleus, polyADP-ribosylation catalyzed by PARP-1 alters protein-protein and protein-DNA interactions, and is implicated in chromatin remodeling, DNA transcription, and repair. Previous results linked the activation of PARP-1 with long-term memory formation during learning in the marine mollusk Aplysia ( Science 2004, 304:1820-1822). Furthermore, PARP-1 was highly activated in mammalian cerebral neurons treated with neurotrophins and neurotrophic peptides promoting neurite outgrowth and synaptic plasticity. Here, we examine the possibility that PARP-1 activation is required for memory formation during learning in mammals. Mice were tested in two learning paradigms, object recognition and fear conditioning. PolyADP-ribosylation of PARP-1 and histone H1 were detected in their cerebral cortex and hippocampus immediately after their training session. Moreover, in both behavioral paradigms, suppression of PARP activity in the CNS during learning impaired their long-term memory formation, without damaging their short-term memory. These findings implicate PARP-1 activation in molecular processes underlying long-term memory formation during learning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19645746     DOI: 10.1111/j.1471-4159.2009.06296.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

Review 1.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

2.  VIP-PACAP 2010: my own perspective on modulation of cognitive and emotional behavior.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2010-11       Impact factor: 3.444

Review 3.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

4.  Characterization of novel cytoplasmic PARP in the brain of Octopus vulgaris.

Authors:  Emilia De Lisa; Anna De Maio; Leonid L Moroz; Francesco Moccia; Maria Rosaria Faraone Mennella; Anna Di Cosmo
Journal:  Biol Bull       Date:  2012-06       Impact factor: 1.818

5.  PARP-1 deletion promotes subventricular zone neural stem cells toward a glial fate.

Authors:  Jennifer M Plane; Steven K Grossenbacher; Wenbin Deng
Journal:  J Neurosci Res       Date:  2012-03-19       Impact factor: 4.164

Review 6.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 7.  Active DNA demethylation in post-mitotic neurons: a reason for optimism.

Authors:  David P Gavin; Kayla A Chase; Rajiv P Sharma
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

8.  PARP-1 is required for retrieval of cocaine-associated memory by binding to the promoter of a novel gene encoding a putative transposase inhibitor.

Authors:  E Lax; A Friedman; R Massart; R Barnea; L Abraham; D Cheishvili; M Zada; H Ahdoot; T Bareli; G Warhaftig; L Visochek; M Suderman; M Cohen-Armon; M Szyf; G Yadid
Journal:  Mol Psychiatry       Date:  2016-09-06       Impact factor: 15.992

9.  Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.

Authors:  K Nho; J J Corneveaux; S Kim; H Lin; S L Risacher; L Shen; S Swaminathan; V K Ramanan; Y Liu; T Foroud; M H Inlow; A L Siniard; R A Reiman; P S Aisen; R C Petersen; R C Green; C R Jack; M W Weiner; C T Baldwin; K Lunetta; L A Farrer; S J Furney; S Lovestone; A Simmons; P Mecocci; B Vellas; M Tsolaki; I Kloszewska; H Soininen; B C McDonald; M R Farlow; B Ghetti; M J Huentelman; A J Saykin
Journal:  Mol Psychiatry       Date:  2013-04-23       Impact factor: 15.992

10.  PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.

Authors:  Bogdan A Stoica; David J Loane; Zaorui Zhao; Shruti V Kabadi; Marie Hanscom; Kimberly R Byrnes; Alan I Faden
Journal:  J Neurotrauma       Date:  2014-01-29       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.